Anixa Biosciences Inc Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Anixa Biosciences Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Anixa Biosciences Inc Entity Common Stock, Shares Outstanding for the quarter ending September 6, 2024 was 32.2M shares, a 3.57% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 32.2M +1.11M +3.57% Sep 6, 2024 10-Q 2024-09-06
Q2 2024 32M +1.03M +3.33% Jun 4, 2024 10-Q 2024-06-04
Q1 2024 31.9M +975K +3.15% Mar 12, 2024 10-Q 2024-03-12
Q4 2023 31.7M +779K +2.52% Jan 16, 2024 10-K 2024-01-16
Q3 2023 31.1M +408K +1.33% Sep 6, 2023 10-Q 2023-09-06
Q2 2023 31M +505K +1.66% Jun 14, 2023 10-Q 2023-06-14
Q1 2023 30.9M +773K +2.56% Mar 16, 2023 10-Q 2023-03-17
Q4 2022 30.9M +788K +2.62% Jan 5, 2023 10-K 2023-01-04
Q3 2022 30.7M +712K +2.38% Sep 9, 2022 10-Q 2022-09-09
Q2 2022 30.5M +521K +1.74% Jun 10, 2022 10-Q 2022-06-10
Q1 2022 30.2M +3.45M +12.9% Mar 11, 2022 10-Q 2022-03-11
Q4 2021 30.1M +4.06M +15.6% Jan 4, 2022 10-K 2022-01-04
Q3 2021 29.9M +6.16M +25.9% Sep 1, 2021 10-Q 2021-09-01
Q2 2021 29.9M +6.97M +30.4% Jun 10, 2021 10-Q 2021-06-10
Q1 2021 26.7M +5.7M +27.1% Mar 11, 2021 10-Q 2021-03-11
Q4 2020 26.1M +5.26M +25.2% Jan 7, 2021 10-K 2021-01-07
Q3 2020 23.8M +3.58M +17.7% Sep 8, 2020 10-Q 2020-09-08
Q2 2020 23M +2.88M +14.3% Jun 9, 2020 10-Q 2020-06-09
Q1 2020 21M +1.38M +7.03% Mar 9, 2020 10-Q 2020-03-09
Q4 2019 20.8M +1.53M +7.93% Jan 8, 2020 10-K 2020-01-09
Q3 2019 20.2M +1.51M +8.08% Sep 5, 2019 10-Q 2019-09-06
Q2 2019 20.1M +1.59M +8.6% Jun 11, 2019 10-Q 2019-06-12
Q1 2019 19.6M +3M +18% Mar 8, 2019 10-Q 2019-03-13
Q4 2018 19.3M +2.68M +16.2% Jan 9, 2019 10-K 2019-01-11
Q3 2018 18.7M +3.58M +23.7% Sep 6, 2018 10-Q 2018-09-07
Q2 2018 18.5M +3.38M +22.4% Jun 5, 2018 10-Q 2018-06-11
Q1 2018 16.6M +7.87M +89.9% Mar 5, 2018 10-Q 2018-03-09
Q4 2017 16.6M +7.86M +89.8% Jan 4, 2018 10-K 2018-01-09
Q3 2017 15.1M +6.37M +72.8% Sep 8, 2017 10-Q 2017-09-08
Q2 2017 15.1M +6.38M +73% May 25, 2017 10-Q 2017-05-26
Q1 2017 8.76M +27.2K +0.31% Mar 14, 2017 10-Q 2017-03-16
Q4 2016 8.75M +27.5K +0.32% Nov 30, 2016 10-K/A 2016-12-08
Q3 2016 8.75M Aug 15, 2016 10-Q 2016-08-19
Q2 2016 8.74M -210M -96% May 16, 2016 10-Q 2016-05-20
Q1 2016 8.73M -211M -96% Feb 15, 2016 10-Q 2016-02-19
Q4 2015 8.72M -211M -96% Dec 17, 2015 10-K 2015-12-23
Q2 2015 219M -1.46M -0.66% May 18, 2015 10-Q 2015-05-22
Q1 2015 220M +6.77M +3.18% Mar 4, 2015 10-Q 2015-03-09
Q4 2014 220M +9.26M +4.4% Jan 23, 2015 10-K 2015-01-29
Q3 2014 217M +9.26M +4.46% Sep 1, 2014 10-Q 2014-09-15
Q2 2014 220M +20.4M +10.2% Jun 10, 2014 10-Q 2014-06-16
Q1 2014 213M +21.2M +11.1% Mar 12, 2014 10-Q 2014-03-17
Q4 2013 210M +25.3M +13.7% Jan 10, 2014 10-K/A 2014-01-17
Q3 2013 208M +22.7M +12.3% Sep 10, 2013 10-Q/A 2013-09-20
Q2 2013 200M +17.3M +9.46% Jun 7, 2013 10-Q/A 2013-06-19
Q1 2013 192M +11.3M +6.26% Mar 11, 2013 10-Q/A 2013-03-25
Q4 2012 185M +5.41M +3.01% Jan 22, 2013 10-K 2013-01-29
Q3 2012 185M +10.4M +5.97% Sep 10, 2012 10-Q 2012-09-14
Q2 2012 183M Jun 8, 2012 10-Q 2012-06-14
Q1 2012 180M Mar 12, 2012 10-Q 2012-03-16
Q4 2011 180M Jan 23, 2012 10-K 2012-01-30
Q3 2011 174M Sep 9, 2011 10-Q/A 2011-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.